drugset / Trial / NCT01242215

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients

NCT01242215

Phase 3 Completed 243 enrolled Astellas Pharma Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is to evaluate the efficacy and safety after concomitant administration of ASP1941 and sulfonylurea in patients with diabetes mellitus.

Timeline

Start
2010-09-17
Primary completion
2012-04-25
Completion
2012-04-25

Drugs

EvaluationDrugModalityDoseRoute
Subject ipragliflozin Small molecule 50 mg Oral
Background Gliclazide Small molecule Oral
Background Glimepiride Small molecule Oral
Background Glyburide Small molecule Oral